Outreach to diversify clinical trial participation: A randomized recruitment study

被引:18
作者
Brown, Susan D. [1 ]
Partee, Paula N. [1 ]
Feng, Juanran [1 ]
Quesenberry, Charles P. [1 ]
Hedderson, Monique M. [1 ]
Ehrlich, Samantha F. [1 ]
Kiernan, Michaela [2 ]
Ferrara, Assiamira [1 ]
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA
[2] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
关键词
Randomized clinical trials; recruitment; participation; racial and ethnic minorities; health disparities; targeting; direct mail; communication; diabetes; disease risk; MINORITY RECRUITMENT; MAILING STRATEGIES; AFRICAN-AMERICANS; DIABETES-MELLITUS; ETHNIC-IDENTITY; INTERVENTION; DISPARITIES; RISK; SELF;
D O I
10.1177/1740774514568125
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aims Racial and ethnic minorities remain underrepresented in clinical research, yet few recruitment strategies have been rigorously evaluated. Methods We experimentally tested whether targeted recruitment letters acknowledging diabetes health disparities and health risks specific to recipients' racial/ethnic group improved two metrics of trial participation: willingness to be screened and enrollment. This experiment was efficiently nested within a randomized clinical trial examining a preventive lifestyle intervention among women at high risk for diabetes. Pregnant women with gestational diabetes or impaired glucose tolerance (N=445) were randomized to receive a targeted recruitment letter with health risk information specific to their racial/ethnic group (n=216), or a standard letter with risk information for the general population (n=229). All letters were bilingual in English and Spanish. Results The targeted as compared to the standard letter did not improve screening or enrollment rates overall or within separate racial/ethnic groups. Among Latina women who preferred Spanish, the targeted letter showed trends for improved screening (66.7% vs 33.3%, p=.06) and enrollment rates (38.9% vs 13.3%, p=.13). In contrast, among Latina women who preferred English, the targeted letter significantly lowered screening (29.6% vs 57.1%, p=.04) and showed trends for lowered enrollment rates (25.9% vs 50.0%, p=.07). Conclusion Results from this randomized study appear to suggest that recruitment letters with diabetes health risk information targeted to recipients' race/ethnicity may improve one metric of clinical trial participation among Latina women who prefer Spanish, but not English. Larger experimental studies, incorporating input from diverse participant stakeholders, are needed to develop evidence-based minority recruitment strategies.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 35 条
[1]  
[Anonymous], RAC ETHN LANG DAT ST
[2]  
[Anonymous], 2010, DIABETES CARE, DOI DOI 10.2337/dc10-s062
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]  
[Anonymous], RACE ETHNICITY CALIF
[5]   Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis [J].
Bellamy, Leanne ;
Casas, Juan-Pablo ;
Hingorani, Aroon D. ;
Williams, David .
LANCET, 2009, 373 (9677) :1773-1779
[6]   Awareness Of Racial And Ethnic Health Disparities Has Improved Only Modestly Over A Decade [J].
Benz, Jennifer K. ;
Espinosa, Oscar ;
Welsh, Valerie ;
Fontes, Angela .
HEALTH AFFAIRS, 2011, 30 (10) :1860-1867
[7]   The "Meaningful Use" Regulation for Electronic Health Records [J].
Blumenthal, David ;
Tavenner, Marilyn .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06) :501-504
[8]  
BRADFORD RH, 1987, CONTROL CLIN TRIALS, V8, pS31
[9]   The Multigroup Ethnic Identity Measure-Revised: Measurement Invariance Across Racial and Ethnic Groups [J].
Brown, Susan D. ;
Hu, Kirsten A. Unger ;
Mevi, Ashley A. ;
Hedderson, Monique M. ;
Shan, Jun ;
Quesenberry, Charles P. ;
Ferrara, Assiamira .
JOURNAL OF COUNSELING PSYCHOLOGY, 2014, 61 (01) :154-161
[10]   Minority recruitment into clinical trials: Experimental findings and practical implications [J].
Brown, Susan D. ;
Lee, Katherine ;
Schoffman, Danielle E. ;
King, Abby C. ;
Crawley, LaVera M. ;
Kiernan, Michaela .
CONTEMPORARY CLINICAL TRIALS, 2012, 33 (04) :620-623